1. Iglehart JK. The mental health maze and the call for transformation. N Engl J Med 2004;350:507–514.
2. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999;56:1073–1086.
3. Townsend L, Floersch J, Findling RL. The conceptual adequacy of the drug attitude inventory for measuring youth attitudes toward psychotropic medications: a mixed methods evaluation. J Mixed Methods Res 2010;4:32–55.
4. Cromer BA, Tarnowski KJ. Non-adherence in adolescents: a review. Develop Behav Pediatr 1989:10:207–215.
5. Lloyd A, Horan W, Borgaro SR, et al. Predictors of medication adherence after hospital discharge in adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry 1998;8:133–141.
6. Friedman RM, Katz-Levey JW, Manderschied RW, et al. Prevalence of serious emotional disturbance in children and adolescent. In Manderscheid RW and Sonnenschein MA, (ed.) Rockville, MD: Center for Mental Health Services. J Ment Health 1996:71–88.
8. Pampallona S, Bollini P, Tibaldi G, et al. Patient adherence in the treatment of depression. Br J Psychiatry 2002;180:104–109.
9. Hamrin V, McCarthy EM, Tyson V. Pediatric psychotropic medication initiation and adherence: a literature review based on social exchange theory. J Child Adolesc Psychiatr Nurs 2010;23:151–172.
10. O’Brien M, Crickard E, Lee J, et al. Attitudes and experience of youth and their parents with psychiatric medication and relationship to self-reported adherence. Community Ment Health J 2013;49:567–575.
11. Moses T. Adolescents’ commitment to continuing psychotropic medication: a preliminary investigation of considerations, contradictions, and correlates. Child Psychiatry Hum Dev 2011;42:93–117.
12. Kinzie JD, Leung P, Boehnlein JK, et al. Antidepressant blood levels in Southeast Asians: clinical and cultural implications. J Nerv Ment Dis 1987;175:480–485.
13. Kroll J, Linde P, Habenicht M, et al. Medication compliance, antidepressant blood levels, and side effects in Southeast Asian patients. J Clin Psychopharmacol 1990;10:279–283.
14. Yang LH, Corsini-Munt S, Link B, et al. Beliefs in traditional Chinese medicine efficacy among Chinese Americans: implications for mental health service utilization. J Nerv Ment Dis 2009;197:207–210. .
15. Yang LH, Kleinman A. “Face” and the embodiment of stigma: schizophrenia and AIDS in China. Social Sci Med 2008;67:398–408.
16. Lin KM, Miller MH, Poland RE, et al. Ethnicity and family involvement in the treatment of schizophrenic patients. J Nerv Ment Dis 1991;179:631–633.
17. Spencer MS, Chen J. Effect of discrimination on mental health service utilization among Chinese Americans. Am J Public Health 2004;94:809–814.
18. Gau SSF, Shen H-Y, Chou M-C, et al. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol 2006;16:286–297.
19. Dean AJ, Wragg J, Draper J, et al. Predictors of medication adherence in children receiving psychotropic medication. J Paediatr Child Health 2011;47:350–355.
20. Bullock A, Patten C. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Epidemiol 2010;45:47–56.
21. Brown RT, Amler RW, Freeman WS, et al. Treatment of attention-deficit/ hyperactivity disorder: overview of the evidence. Pediatrics 2005;115: e749–e757.
22. Faraone SV, Sergeant J, Gilberg C, et al. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2003;2:104–113.
23. Gau SS, Chen SJ, Chou WJ, et al. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/ hyperactivity disorder in Taiwan. J Clin Psychiatry 2008;69:131–140.
24. Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry 2001;40:922–928.
25. Logan SL, Carpenter LA, Leslie RS, et al. Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders. J Autism Develop Disorders 2014;44:2931–2948.
27. Chacko A, Newcorn J, Feirsen N, et al. Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth. Curr Pharm Des 2010;16:2416–2423.
28. Thompson C, Peveler RC, Stephenson D, et al. Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant. Am J Psychiatry 2000;157, 338–343.
29. Cañas F, Alptekin K, Azorin JM, et al. Improving treatment adherence in your patients with schizophrenia: the STAY initiative. Clin Drug Investig 2013;33:97–107.
30. Mitchell W, Scheeier L, Baker SA. Adherence to treatment in children with epilepsy: who follows “doctor’s orders?” Epilepsia 2000;41:616–625.
31. Faught E, Duh MS, Weiner JR, et al. Non-adherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology 2008;17:1572–1578.
32. Drotar D, Neff Greenley R, Demeter CA, et al. Adherence to pharmacological treatment for juvenile bipolar disorder. J Am Acad Child Adolesc Psychiatry 2007;46:831–839.
33. Rickles NM, Svarstad BL. Relationships between multiple self-reported non-adherence measures and pharmacy records. Res Social Adm Pharm 2007;3:363–377.
34. Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int 2015;2015:217047.
35. Svarstad BL, Chewning BA, Sleath BL, et al. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999;37:113–124.
36. Alegria M, Polo A, Gao S, et al. Evaluation of a patient’s activation and empowerment intervention in mental health care. Med Care 2008;46:247–256.
37. Deegan PE, Drake RE. Shared decision making and medication management in the recovery process. Psychiatr Serv 2006;57:1636–1639.
38. Dilallo JJ, Weiss G. Motivational interviewing and adolescent psychopharmacology. J Am Acad Child Adolesc Psychiatry 2009;48:108–113.
39. Townsend L, Floersch J, Findling RL. Adolescent attitudes toward psychiatric medication: the utility of the Drug Attitude Inventory. J Child Psychol Psychiatry 2009;50:1523–1531.
40. Floersch J, Townsend L, Longhofer J, et al. Adolescent experience of psychotropic treatment. Transcult Psychiatry 2009;46:157–179.
41. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983;13:177–183.
43. Parchman ML, Zeber JE, Palmer RF. Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study. Ann Fam Med 2010;8:410–417.
44. Hunsley J. Development of the Treatment Acceptability Questionnaire. J Psychopathol Behav Assess 1992;14:55–64.
45. Coyne I. Consultation with children in hospital: children, parents’ and nurses’ perspectives. J Clin Nurs 2006;15:61–71.
46. Kelsey J, Abelson-Mitchell N, Skirton H. Perceptions of young people about decision making in the acute healthcare environment. Paediatr Nurs 2007;19:14–18.
47. Alderson P, Sutcliffe K, Curtis K. Children’s competence to consent to medical treatment. Hastings Cent Rep 2006;36:25–34.
48. Hammonds T, Rickert K, Goldstein C, et al. Adherence to antidepressant medications: a randomized controlled trial of medication reminding in college students. J Am Coll Health 2015;63:204–208.
49. Longhofer J, Floersch J. Desire and disappointment: adolescent psychotropic treatment and adherence. Anthropol Med 2010;17:159–172.
50. Longhofer J, Floersch J, Okpych N. Foster youth and psychotropic treatment: where next? Child Youth Serv Rev 2011;33:395–404.
51. King G, Currie M, Petersen P. Child and parent engagement in the mental health intervention process: a motivational framework. Child Adolesc Ment Health 2014;19:2–8.
52. Mucka L, Hinrichs J, Upton F, et al. Barriers to adherence to child assessment recommendations. J Child Fam Stud 2017;26:1029–1039.
53. Hébert J, Polotskaia A, Joober R, et al. Adherence to psychostimulant medication in children with attention-deficit/hyperactivity disorder: the role of attitudes. J Can Acad Child Adolesc Psychiatry 2013;22:317–323.
54. Schwalbe CS, Gearing RE, MacKenzie MJ, et al. A meta-analysis of experimental studies of diversion programs for juvenile offenders. Clin Psychol Rev 2012;32:26–33.
55. Ran M, Xiang M. A study of schizophrenic patients’ treatment compliance in a rural community. J Ment Health 1995;4:85–89.
56. Ran M-S, Xiang M-Z, Chan CL-W, et al. Effectiveness of psychoeducational intervention for rural Chinese families experiencing schizophrenia: a randomised controlled trial. Soc Psychiatry Psychiatr Epidemiol 2003;38:69–75.
57. Tay S-EC. Compliance therapy: an intervention to improve inpatients’ attitudes toward treatment. J Psychosoc Nurs Ment Health Serv 2007;45:29–37.
58. Li Z, Arthur D. Family education for people with schizophrenia in Beijing, China: randomised controlled trial. Br J Psychiatry 2005;187:339–345.
59. Xiang M, Ran M, Li S. A controlled evaluation of psychoeducational family intervention in a rural Chinese community. Br J Psychiatry 1994;165:544–548.
60. Chan SW-C, Yip B, Tso S, et al. Evaluation of a psychoeducation program for Chinese clients with schizophrenia and their family caregivers. Patient Educ Couns 2009;75:67–76.
61. Maneesakorn S, Robson D, Gournay K, et al. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J Clin Nurs 2007;16:1302–1312.
62. Fancher TL, Lee D, Cheng JKY, et al. Interventions to improve adherence to psychotropic medication in clients of Asian descent: a systematic review. Asian Am J Psychol 2014;5:22–34.